IceCure Medical Ltd (ICCM)
NASDAQ: ICCM · Real-Time Price · USD
1.410
-0.090 (-6.00%)
Feb 21, 2025, 4:00 PM EST - Market closed
IceCure Medical Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Revenue | 3.67 | 3.23 | 3.09 | 4.14 | 3.87 | 5.74 | Upgrade
|
| Revenue Growth (YoY) | 26.02% | 4.67% | -25.45% | 6.98% | -32.61% | 42.18% | Upgrade
|
| Cost of Revenue | 2.07 | 1.93 | 1.64 | 1.94 | 1.42 | 3.74 | Upgrade
|
| Gross Profit | 1.6 | 1.3 | 1.45 | 2.2 | 2.44 | 2 | Upgrade
|
| Selling, General & Admin | 8.91 | 8.6 | 9.06 | 6.04 | 2.78 | 8.1 | Upgrade
|
| Research & Development | 7.28 | 8.27 | 9.12 | 5.88 | 3.81 | 9.86 | Upgrade
|
| Operating Expenses | 16.19 | 16.88 | 18.18 | 11.92 | 6.59 | 17.96 | Upgrade
|
| Operating Income | -14.59 | -15.58 | -16.74 | -9.72 | -4.14 | -15.96 | Upgrade
|
| Interest Expense | - | - | -0.24 | -0.17 | - | -0.08 | Upgrade
|
| Interest & Investment Income | 0.75 | 0.92 | - | - | 0.41 | - | Upgrade
|
| Currency Exchange Gain (Loss) | - | - | - | - | - | 0.13 | Upgrade
|
| Other Non Operating Income (Expenses) | - | - | - | - | - | -0.62 | Upgrade
|
| Pretax Income | -13.83 | -14.65 | -16.98 | -9.9 | -3.73 | -16.53 | Upgrade
|
| Net Income | -13.83 | -14.65 | -16.98 | -9.9 | -3.73 | -16.53 | Upgrade
|
| Net Income to Common | -13.83 | -14.65 | -16.98 | -9.9 | -3.73 | -16.53 | Upgrade
|
| Shares Outstanding (Basic) | 48 | 46 | 37 | 29 | 17 | 14 | Upgrade
|
| Shares Outstanding (Diluted) | 48 | 46 | 37 | 29 | 17 | 14 | Upgrade
|
| Shares Change (YoY) | 10.71% | 23.29% | 29.66% | 66.67% | 25.75% | 16.74% | Upgrade
|
| EPS (Basic) | -0.29 | -0.32 | -0.46 | -0.35 | -0.22 | -1.21 | Upgrade
|
| EPS (Diluted) | -0.29 | -0.32 | -0.46 | -0.35 | -0.22 | -1.21 | Upgrade
|
| Free Cash Flow | -10.79 | -13 | -15.18 | -13.14 | -3.91 | -6.39 | Upgrade
|
| Free Cash Flow Per Share | -0.22 | -0.28 | -0.41 | -0.46 | -0.23 | -0.47 | Upgrade
|
| Gross Margin | 43.67% | 40.26% | 46.84% | 53.04% | 63.19% | 34.77% | Upgrade
|
| Operating Margin | -397.33% | -482.38% | -542.59% | -234.99% | -107.08% | -278.03% | Upgrade
|
| Profit Margin | -376.85% | -453.76% | -550.34% | -239.13% | -96.43% | -288.00% | Upgrade
|
| Free Cash Flow Margin | -293.93% | -402.63% | -492.16% | -317.50% | -101.16% | -111.25% | Upgrade
|
| EBITDA | -14.25 | -15.25 | -16.49 | -9.6 | -4.08 | -15.86 | Upgrade
|
| EBITDA Margin | - | - | - | -231.92% | -105.45% | -276.24% | Upgrade
|
| D&A For EBITDA | 0.33 | 0.32 | 0.25 | 0.13 | 0.06 | 0.1 | Upgrade
|
| EBIT | -14.59 | -15.58 | -16.74 | -9.72 | -4.14 | -15.96 | Upgrade
|
| EBIT Margin | - | - | - | -234.99% | -107.08% | -278.03% | Upgrade
|
| Advertising Expenses | - | 0.09 | 0.07 | 0.06 | 0.04 | 0.15 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.